A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients

Clinical trial NCT01634243 · COMPLETED

Trial details

NCT number: NCT01634243
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2005-01-01
Primary completion: 2006-05-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.